<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26231035</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>7</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>HCV NS5A Up-Regulates COX-2 Expression via IL-8-Mediated Activation of the ERK/JNK MAPK Pathway.</ArticleTitle><Pagination><StartPage>e0133264</StartPage><MedlinePgn>e0133264</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0133264</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0133264</ELocationID><Abstract><AbstractText>Chronic hepatitis C virus (HCV) infection leads to intrahepatic inflammation and liver cell injury, which are considered a risk factor for virus-associated hepatitis, cirrhosis, and hepatocellular carcinoma worldwide. Inflammatory cytokines are critical components of the immune system and influence cellular signaling, and genetic imbalances. In this study, we found that cyclooxygenase-2 (COX-2) and interleukin-8 (IL-8) were significantly induced by HCV infection and HCV NS5A expression, and induction of COX-2 correlated with HCV-induced IL-8 production. We also found that the ERK and JNK signaling pathways were involved in the regulation of IL-8-mediated COX-2 induction in response to HCV infection. Using a promoter-linked reporter assay, we identified that the C/EBP regulatory element within the COX-2 promoter was the dominant factor responsible for the induction of COX-2 by HCV. Silencing C/EBP attenuated HCV-induced COX-2 expression. Our results revealed that HCV-induced inflammation promotes viral replication, providing new insights into the involvement of IL-8-mediated COX-2 induction in HCV replication.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wei-Chun</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Chin-Kai</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Center of Infectious Disease and Signaling Research, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yen-Hsu</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; School of Medicine, Graduate Institute of Medicine, Sepsis Research Center, Center for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, HsinChu, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chun-Kuang</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Doctoral Degree Program in Marine Biotechnology, National Sun Yat-Sen University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Shih-Hsien</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shen-Nien</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Division of Hepatobiliary Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Department of Surgery, Faculty of Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jin-Ching</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, College of Life Science, Kaohsiung Medical University, Kaohsiung, Taiwan; Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016209">Interleukin-8</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.99.1</RegistryNumber><NameOfSubstance UI="D051546">Cyclooxygenase 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.48</RegistryNumber><NameOfSubstance UI="C087036">NS-5 protein, hepatitis C virus</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051546" MajorTopicYN="N">Cyclooxygenase 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016209" MajorTopicYN="N">Interleukin-8</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020935" MajorTopicYN="Y">MAP Kinase Signaling System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="Y">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26231035</ArticleId><ArticleId IdType="pmc">PMC4521820</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0133264</ArticleId><ArticleId IdType="pii">PONE-D-15-15799</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alter MJ. Epidemiology of hepatitis C virus infection. World journal of gastroenterology: WJG. 2007;13(17):2436&#x2013;41. Epub 2007/06/07. .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4146761</ArticleId><ArticleId IdType="pubmed">17552026</ArticleId></ArticleIdList></Reference><Reference><Citation>Levrero M. Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene. 2006;25(27):3834&#x2013;47. Epub 2006/06/27. 10.1038/sj.onc.1209562 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1209562</ArticleId><ArticleId IdType="pubmed">16799625</ArticleId></ArticleIdList></Reference><Reference><Citation>Dessouki O, Kamiya Y, Nagahama H, Tanaka M, Suzu S, Sasaki Y, et al. Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: Reversion by anti-viral treatment. Biochemical and biophysical research communications. 2010;393(2):331&#x2013;7. Epub 2010/02/09. 10.1016/j.bbrc.2010.02.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2010.02.008</ArticleId><ArticleId IdType="pubmed">20138830</ArticleId></ArticleIdList></Reference><Reference><Citation>Petta S, Craxi A. Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association. Current pharmaceutical design. 2010;16(6):741&#x2013;52. Epub 2010/04/15. .</Citation><ArticleIdList><ArticleId IdType="pubmed">20388084</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmanouil Kochlios PFaPM. Modulation of monocyte/macrophage-derived cytokine and chemokine expression profile by persistent Hepatitis C virus (HCV) infection leads to chronic inflammation. Journal of Molecular Biochemistry. 2012;1(1):40&#x2013;53.</Citation></Reference><Reference><Citation>Aghemo A, Colombo M. Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside. Seminars in immunopathology. 2013;35(1):111&#x2013;20. 10.1007/s00281-012-0330-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-012-0330-z</ArticleId><ArticleId IdType="pubmed">23010890</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacological reviews. 2004;56(3):387&#x2013;437. 10.1124/pr.56.3.3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.56.3.3</ArticleId><ArticleId IdType="pubmed">15317910</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel A, Boland CR, Chauhan DP. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer letters. 2001;172(2):111&#x2013;8. .</Citation><ArticleIdList><ArticleId IdType="pubmed">11566484</ArticleId></ArticleIdList></Reference><Reference><Citation>Senthil Kumar KJ, Wang SY. Lucidone inhibits iNOS and COX-2 expression in LPS-induced RAW 264.7 murine macrophage cells via NF-kappaB and MAPKs signaling pathways. Planta medica. 2009;75(5):494&#x2013;500. 10.1055/s-0029-1185309 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0029-1185309</ArticleId><ArticleId IdType="pubmed">19194838</ArticleId></ArticleIdList></Reference><Reference><Citation>Steer SA, Corbett JA. The role and regulation of COX-2 during viral infection. Viral immunology. 2003;16(4):447&#x2013;60. 10.1089/088282403771926283 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/088282403771926283</ArticleId><ArticleId IdType="pubmed">14733733</ArticleId></ArticleIdList></Reference><Reference><Citation>Tveteraas IH, Muller KM, Aasrum M, Odegard J, Dajani O, Guren T, et al. Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells. Journal of experimental &amp; clinical cancer research: CR. 2012;31:72 Epub 2012/09/13. 10.1186/1756-9966-31-72</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-9966-31-72</ArticleId><ArticleId IdType="pmc">PMC3542006</ArticleId><ArticleId IdType="pubmed">22967907</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss SF, Blaser MJ. Mechanisms of disease: Inflammation and the origins of cancer. Nature clinical practice Oncology. 2005;2(2):90&#x2013;7; quiz 1 p following 113. 10.1038/ncponc0081 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncponc0081</ArticleId><ArticleId IdType="pubmed">16264881</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clinical cancer research: an official journal of the American Association for Cancer Research. 2009;15(2):425&#x2013;30. 10.1158/1078-0432.CCR-08-0149 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-08-0149</ArticleId><ArticleId IdType="pubmed">19147746</ArticleId></ArticleIdList></Reference><Reference><Citation>Trujillo-Murillo K, Alvarez-Martinez O, Garza-Rodriguez L, Martinez-Rodriguez H, Bosques-Padilla F, Ramos-Jimenez J, et al. Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity. Journal of viral hepatitis. 2007;14(9):608&#x2013;17. 10.1111/j.1365-2893.2006.00837.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2893.2006.00837.x</ArticleId><ArticleId IdType="pubmed">17697012</ArticleId></ArticleIdList></Reference><Reference><Citation>Trujillo-Murillo K, Rincon-Sanchez AR, Martinez-Rodriguez H, Bosques-Padilla F, Ramos-Jimenez J, Barrera-Saldana HA, et al. Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways. Hepatology. 2008;47(5):1462&#x2013;72. 10.1002/hep.22215 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.22215</ArticleId><ArticleId IdType="pubmed">18393288</ArticleId></ArticleIdList></Reference><Reference><Citation>Zampino R, Marrone A, Restivo L, Guerrera B, Sellitto A, Rinaldi L, et al. Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World journal of hepatology. 2013;5(10):528&#x2013;40. 10.4254/wjh.v5.i10.528</Citation><ArticleIdList><ArticleId IdType="doi">10.4254/wjh.v5.i10.528</ArticleId><ArticleId IdType="pmc">PMC3812455</ArticleId><ArticleId IdType="pubmed">24179612</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annual review of immunology. 2000;18:217&#x2013;42. 10.1146/annurev.immunol.18.1.217 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.18.1.217</ArticleId><ArticleId IdType="pubmed">10837058</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. International journal of hematology. 2000;72(4):391&#x2013;8. Epub 2001/02/24. .</Citation><ArticleIdList><ArticleId IdType="pubmed">11197203</ArticleId></ArticleIdList></Reference><Reference><Citation>Roebuck KA. Regulation of interleukin-8 gene expression. Journal of interferon &amp; cytokine research: the official journal of the International Society for Interferon and Cytokine Research. 1999;19(5):429&#x2013;38. .</Citation><ArticleIdList><ArticleId IdType="pubmed">10386854</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollicino T, Bellinghieri L, Restuccia A, Raffa G, Musolino C, Alibrandi A, et al. Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. Virology. 2013;444(1&#x2013;2):317&#x2013;28. 10.1016/j.virol.2013.06.028 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2013.06.028</ArticleId><ArticleId IdType="pubmed">23890815</ArticleId></ArticleIdList></Reference><Reference><Citation>Markaverich BM, Crowley J, Rodriquez M, Shoulars K, Thompson T. Tetrahydrofurandiol stimulation of phospholipase A2, lipoxygenase, and cyclooxygenase gene expression and MCF-7 human breast cancer cell proliferation. Environmental health perspectives. 2007;115(12):1727&#x2013;31. 10.1289/ehp.10659</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.10659</ArticleId><ArticleId IdType="pmc">PMC2137134</ArticleId><ArticleId IdType="pubmed">18087590</ArticleId></ArticleIdList></Reference><Reference><Citation>Vendramini-Costa DB, Carvalho JE. Molecular Link Mechanisms between Inflammation and Cancer. Current pharmaceutical design. 2012;18(26):3831&#x2013;52. .</Citation><ArticleIdList><ArticleId IdType="pubmed">22632748</ArticleId></ArticleIdList></Reference><Reference><Citation>Hany Elewa MA-E, Ahmed Murad Hashem, Aml Alshehaby. Study of interleukin 8 (IL8) serum level in patients with chronic liver disease due to hepatitis C virus (HCV) with and without hepatocellular carcinoma (HCC). International Journal of Hepatology 2010;1(3):9&#x2013;17.</Citation></Reference><Reference><Citation>Lee CM, Yen YH, Hung CH, Lu SN, Wang JH, Wang JC, et al. Liver interleukin-8 messenger RNA expression and interferon sensitivity-determining region mutations relate to treatment response in hepatitis C 1b. Antiviral therapy. 2011;16(6):825&#x2013;32. 10.3851/IMP1868 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3851/IMP1868</ArticleId><ArticleId IdType="pubmed">21900714</ArticleId></ArticleIdList></Reference><Reference><Citation>Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science. 2000;290(5498):1972&#x2013;4. .</Citation><ArticleIdList><ArticleId IdType="pubmed">11110665</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato T, Wakita T. [Production of infectious hepatitis C virus in cell culture]. Uirusu. 2005;55(2):287&#x2013;95. .</Citation><ArticleIdList><ArticleId IdType="pubmed">16557015</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JC, Chen WC, Wu SF, Tseng CK, Chiou CY, Chang FR, et al. Anti-hepatitis C virus activity of Acacia confusa extract via suppressing cyclooxygenase-2. Antiviral research. 2011;89(1):35&#x2013;42. 10.1016/j.antiviral.2010.11.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2010.11.003</ArticleId><ArticleId IdType="pubmed">21075144</ArticleId></ArticleIdList></Reference><Reference><Citation>Abmayr SM, Yao T, Parmely T, Workman JL. Preparation of nuclear and cytoplasmic extracts from mammalian cells. Current protocols in molecular biology / edited by Frederick M Ausubel [et al.]. 2006;Chapter 12:Unit 12 1. 10.1002/0471142727.mb1201s75 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142727.mb1201s75</ArticleId><ArticleId IdType="pubmed">18265374</ArticleId></ArticleIdList></Reference><Reference><Citation>
Jahan S, Khaliq S, Ijaz B, Ahmad W, Hassan S. Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis. Virol J. 2011;8:155 Epub 2011/04/05. doi: 10.1186/1743-422X-8-155 1743-422X-8-155 [pii]. </Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-1551743-422X-8-155</ArticleId><ArticleId IdType="pmc">PMC3080829</ArticleId><ArticleId IdType="pubmed">21457561</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L, Wei L, Peng G, Mu Y, Wu K, Kang L, et al. NS3 protein of hepatitis C virus regulates cyclooxygenase-2 expression through multiple signaling pathways. Virology. 2008;371(1):61&#x2013;70. Epub 2007/10/30. doi: S0042-6822(07)00592-2 [pii] 10.1016/j.virol.2007.09.025 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2007.09.025</ArticleId><ArticleId IdType="pmc">PMC7103338</ArticleId><ArticleId IdType="pubmed">17964630</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura-Sakurai Y, Sakamoto N, Mogushi K, Nagaie S, Nakagawa M, Itsui Y, et al. Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells. J Gastroenterol. 2010;45(5):523&#x2013;36. Epub 2009/12/17. 10.1007/s00535-009-0162-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-009-0162-3</ArticleId><ArticleId IdType="pubmed">20012654</ArticleId></ArticleIdList></Reference><Reference><Citation>Gales D, Clark C, Manne U, Samuel T. The Chemokine CXCL8 in Carcinogenesis and Drug Response. ISRN oncology. 2013;2013:859154 10.1155/2013/859154</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/859154</ArticleId><ArticleId IdType="pmc">PMC3810054</ArticleId><ArticleId IdType="pubmed">24224100</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu XZ. New strategy of antiangiogenic therapy for hepatocellular carcinoma. Neoplasma. 2008;55(6):472&#x2013;81. .</Citation><ArticleIdList><ArticleId IdType="pubmed">18999874</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper KA, Tyson-Capper AJ. Complexity of COX-2 gene regulation. Biochemical Society transactions. 2008;36(Pt 3):543&#x2013;5. 10.1042/BST0360543 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST0360543</ArticleId><ArticleId IdType="pubmed">18482003</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownell J, Polyak SJ. Molecular pathways: hepatitis C virus, CXCL10, and the inflammatory road to liver cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2013;19(6):1347&#x2013;52. 10.1158/1078-0432.CCR-12-0928</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-12-0928</ArticleId><ArticleId IdType="pmc">PMC3602344</ArticleId><ArticleId IdType="pubmed">23322900</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiba J, Yano H, Ogasawara S, Higaki K, Kojiro M. Expression and function of interleukin-8 in human hepatocellular carcinoma. International journal of oncology. 2001;18(2):257&#x2013;64. .</Citation><ArticleIdList><ArticleId IdType="pubmed">11172590</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang KH, Ma S, Lee TK, Chan YP, Kwan PS, Tong CM, et al. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling. Hepatology. 2012;55(3):807&#x2013;20. 10.1002/hep.24739 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.24739</ArticleId><ArticleId IdType="pubmed">21994122</ArticleId></ArticleIdList></Reference><Reference><Citation>Sertic J, Slavicek J, Bozina N, Malenica B, Kes P, Reiner Z. Cytokines and growth factors in mostly atherosclerotic patients on hemodialysis determined by biochip array technology. Clinical chemistry and laboratory medicine: CCLM / FESCC. 2007;45(10):1347&#x2013;52. 10.1515/CCLM.2007.321 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/CCLM.2007.321</ArticleId><ArticleId IdType="pubmed">17924848</ArticleId></ArticleIdList></Reference><Reference><Citation>Buck M, Chojkier M. C/EBPbeta associates with caspase 8 complex proteins and modulates apoptosis in hepatic stellate cells. Journal of clinical gastroenterology. 2007;41 Suppl 3:S295&#x2013;9. 10.1097/MCG.0b013e31814927d5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCG.0b013e31814927d5</ArticleId><ArticleId IdType="pubmed">17975479</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Liang Y-NH, Shui-Xiang He, Yuan Deng, Xiao-Feng Li, Ya-Xin Zhang, He-Lei Hou, et al. Significance of COX-2 and C/EBP &#x3b2; expression in hepatocellular carcinoma World Chinese Journal of Digestology. 2010;18(28):3040&#x2013;4.</Citation></Reference><Reference><Citation>Lu XL, He SX, Ren MD, Wang YL, Zhang YX, Liu EQ. Chemopreventive effect of saikosaponin-d on diethylinitrosamine-induced hepatocarcinogenesis: involvement of CCAAT/enhancer binding protein beta and cyclooxygenase-2. Molecular medicine reports. 2012;5(3):637&#x2013;44. 10.3892/mmr.2011.702 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2011.702</ArticleId><ArticleId IdType="pubmed">22159471</ArticleId></ArticleIdList></Reference><Reference><Citation>Qadri I, Choudhury M, Rahman SM, Knotts TA, Janssen RC, Schaack J, et al. Increased phosphoenolpyruvate carboxykinase gene expression and steatosis during hepatitis C virus subgenome replication: role of nonstructural component 5A and CCAAT/enhancer-binding protein beta. The Journal of biological chemistry. 2012;287(44):37340&#x2013;51. 10.1074/jbc.M112.384743</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.384743</ArticleId><ArticleId IdType="pmc">PMC3481331</ArticleId><ArticleId IdType="pubmed">22955269</ArticleId></ArticleIdList></Reference><Reference><Citation>Reshi ML, Su YC, Hong JR. RNA Viruses: ROS-Mediated Cell Death. International journal of cell biology. 2014;2014:467452 10.1155/2014/467452</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/467452</ArticleId><ArticleId IdType="pmc">PMC4034720</ArticleId><ArticleId IdType="pubmed">24899897</ArticleId></ArticleIdList></Reference><Reference><Citation>Han C, Demetris AJ, Stolz DB, Xu L, Lim K, Wu T. Modulation of Stat3 activation by the cytosolic phospholipase A2alpha and cyclooxygenase-2-controlled prostaglandin E2 signaling pathway. The Journal of biological chemistry. 2006;281(34):24831&#x2013;46. 10.1074/jbc.M602201200 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M602201200</ArticleId><ArticleId IdType="pubmed">16790433</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Wang DS, Li QJ, Sun W, Zhang Y, Dou KF. The down-regulation of Notch1 inhibits the invasion and migration of hepatocellular carcinoma cells by inactivating the cyclooxygenase-2/Snail/E-cadherin pathway in vitro. Digestive diseases and sciences. 2013;58(4):1016&#x2013;25. 10.1007/s10620-012-2434-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-012-2434-7</ArticleId><ArticleId IdType="pubmed">23053901</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JC, Tseng CK, Wu SF, Chang FR, Chiu CC, Wu YC. San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression. Journal of viral hepatitis. 2011;18(7):e315&#x2013;24. 10.1111/j.1365-2893.2010.01424.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2893.2010.01424.x</ArticleId><ArticleId IdType="pmc">PMC7185454</ArticleId><ArticleId IdType="pubmed">21692943</ArticleId></ArticleIdList></Reference><Reference><Citation>Waris G, Siddiqui A. Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication. Journal of virology. 2005;79(15):9725&#x2013;34. 10.1128/JVI.79.15.9725-9734.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.15.9725-9734.2005</ArticleId><ArticleId IdType="pmc">PMC1181604</ArticleId><ArticleId IdType="pubmed">16014934</ArticleId></ArticleIdList></Reference><Reference><Citation>Polyak SJ, Khabar KS, Paschal DM, Ezelle HJ, Duverlie G, Barber GN, et al. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. Journal of virology. 2001;75(13):6095&#x2013;106. 10.1128/JVI.75.13.6095-6106.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.13.6095-6106.2001</ArticleId><ArticleId IdType="pmc">PMC114325</ArticleId><ArticleId IdType="pubmed">11390611</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>